Next Article in Journal
Design of Na3MnZr(PO4)3/Carbon Nanofiber Free-Standing Cathodes for Sodium-Ion Batteries with Enhanced Electrochemical Performances through Different Electrospinning Approaches
Previous Article in Journal
CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity
Previous Article in Special Issue
Diastereoselective Three-Component 1,3-Dipolar Cycloaddition to Access Functionalized β-Tetrahydrocarboline- and Tetrahydroisoquinoline-Fused Spirooxindoles
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 8
10.3390/molecules29081884
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Novel Biopolymer-Based Catalyst for the Multicomponent Synthesis of N-aryl-4-aryl-Substituted Dihydropyridines Derived from Simple and Complex Anilines

by
Giovanna Bosica
* and
Roderick Abdilla
Green Synthetic Organic Chemistry Lab, Department of Chemistry, University of Malta, 2080 Msida, Malta
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(8), 1884; https://doi.org/10.3390/molecules29081884
Submission received: 14 March 2024 / Revised: 12 April 2024 / Accepted: 18 April 2024 / Published: 20 April 2024
(This article belongs to the Special Issue Multicomponent Reactions in Organic Synthesis)
Browse Figures
Review Reports Versions Notes

Abstract

:
Although Hantzsch synthesis has been an established multicomponent reaction method for more than a decade, its derivative, whereby an aniline replaces ammonium acetate as the nitrogen source, has not been explored at great length. Recent studies have shown that the products of such a reaction, N-aryl-4-aryldihydropyridines (DHPs), have significant anticancer activity. In this study, we successfully managed to synthesize a wide range of DHPs (18 examples, 8 of which were novel) using a metal-free, mild, inexpensive, recoverable, and biopolymer-based heterogeneous catalyst, known as piperazine, which was supported in agar–agar gel. In addition, 8 further examples (3 novel) of such dihydropyridines were synthesized using isatin instead of aldehyde as a reactant, producing spiro-linked structures. Lastly, this catalyst managed to afford an unprecedented product that was derived using an innovative technique—a combination of multicomponent reactions. Essentially, the product of our previously reported aza-Friedel–Crafts multicomponent reaction could itself be used as a reactant instead of aniline in the synthesis of more complex dihydropyridines.

Graphical Abstract

1. Introduction

In recent decades, the concept of multicomponent reactions (MCRs) has percolated into synthetic organic chemistry because of green and environmental considerations [1]. Reductions in reaction time, purification length, and solvent use, as well as the ability to synthesize final complex products that cannot be formed otherwise, are some of the inherent advantages of using MCRs. These can be catalysed by various methods, such as by the use of magnetic nanocatalysts or aqueous micelles [2,3,4]. In relation to this, dihydropyridines (DHPs) have long been synthesized via the classical Hantzsch MCR synthesis using a broad range of catalysts, deep eutectic solvents, ionic liquids, microwave/ultrasound radiation, etc. [5,6]. Without doubt, such advances could be driven further because of the significant biological activity exhibited by these scaffolds, as is attested by their incorporation into drugs including nifedipine, amlodipine, and oxodipine (all of which are antihypertensive and antianginal) [7]. Furthermore, a recent publication by our research group showed that N-unsubstituted DHPs exhibit significant anti-proliferative activity against various human cancer cells [8].
Notwithstanding the fact that the classic Hantzsch synthesis has been extensively researched, work on the related synthesis, whereby the nitrogen source is an aromatic/aliphatic amine (instead of ammonia/ammonium acetate), has been given relatively less attention. That said, there are studies which suggest that N-aryl-4-aryldihydropyridines (Figure 1) demonstrate significant anticancer activity. Specifically, sulfonamide-bearing N-aryl-substituted dihydropyridines are highly active because they are able to inhibit the activity of carbonic anhydrase isoenzyme (catalyses cellular conversion of carbon dioxide into bicarbonate) [9,10].
One approach to synthesizing the above structures or similar ones necessitates the combination of arylamines (1), aldehydes (2), dimedone/1,3-cyclohexandione (3), and malononitrile (4), as portrayed in Scheme 1. In truth, one can also arrive at the same final product (5) by combining a previously formed sample of the condensation product of the amine and dimedone/1,3-cyclohexandione (the enaminone, structure I, Figure 2) and the Knoevenagel product of the reaction between the aldehyde and malononitrile (the arylidene malononitrile, structure II, Figure 2), as reported in a study performed in DMSO [11].
The current state of the art for the synthesis of the product scaffold shown in Scheme 1 includes the use of magnesium oxide nanoparticles [12], zinc oxide nanoparticles (in presence of ultrasound radiation) [13], magnetite [14], triazine diamine-functionalised silica-coated manganese ferrite [15], DBU (in the presence of microwave radiation) [16], molecular sieves (in DMSO solvent, two-component version) [11], chitosan (two-component version) [17], [18-C-6Na][3-NO2-C6H4-SO3] crown ether [18], hexamethylenetetramine-based ionic liquid anchored onto MIL-101 [19], and tetrabutylammonium fluoride (two-component version) [20]. Yet, most of these catalysts suffer from one or more disadvantages, especially in terms of the catalyst’s nature and synthesis. In fact, a significant number of them are metal-based, while others require complex hazardous synthetic pathways. Additionally, there have been few attempts at using other functionalised anilines. In light of this, we are reporting the use of the biodegradable, cheap, and easily synthesizable metal-free catalyst piperazine after its incorporation into agar. Such a novel catalyst was discovered to be fitting for the mentioned dihydropyridines, as well as for other MCR studies that are ongoing.
In addition to the above, the aldehyde can be replaced by isatin (6) to form spiro-linked N-aryl-4-aryl DHP compounds (7a), as portrayed in Scheme 2 and as reported by Lee, Y.R. et al., who performed the reaction in tetrahydrofuran solvent, using ethylene diacetate as an ionic salt [21]. Positively, in our study, the developed catalyst could be used to form various isatin-derived dihydropyridines in ethanol solvent in appreciable yields.

2. Results and Discussion

2.1. Catalyst Screening and Condition Optimisation

For the model reaction required to identify the optimum conditions, aniline (1a), benzaldehyde (2a), dimedone (3a), and malononitrile (4a) were chosen as the reactants. In an elaborate set of catalyst screening and condition optimisation trials (Table 1), it was immediately evident that it was ideal to first stir at 85 °C in the neat conditions 1a and 3a to form the enaminone, before then adding the catalyst and the solvent, 4a and 2a (in that order). This was because, when the reactants had been added contemporarily along with the catalyst, the main product that formed was the 4H-benzopyran, produced from the combination of dimedone, malononitrile, and the aldehyde (Scheme 3) [22]. In fact, the formation of the latter was one of the recurring issues in the optimisation runs, especially because of the fact that during recrystallization both the expected product (5a) and the aforementioned side product (8a) precipitated out.
Considering that the previous research completed by our group had identified piperazine supported on Amberlyst® 15 as an ideal catalyst for the combination of salicylaldehyde, malononitrile, and nucleophilic species, the latter catalyst was tried in the first couple of screening runs [23]. Increasing the reaction time of the second part of the reaction was evidently beneficial (Table 1, entry 1 vs. entry 3), and it was also ideal to leave dimedone and aniline to react for long enough before adding the remainder of the reactants (Table 1, entry 1 vs. entry 2). Increasing the catalyst amount (entry 13) or adding molecular sieves (Table 1, entry 10) both helped to improve the yield further. However, there was still significant room for yield improvement.
Replacing piperazine with either ethylenediamine or morpholine as the supported base on Amberlyst® 15 did not help to resolve the issue (Table 1, entries 8, 9). Furthermore, upon replacing the acidic support (Amberlyst® 15) with Dowex® 50Wx8-50-100, the yield values remained fairly similar (Table 1, entries 10–16). However, when the aldehyde and malononitrile equivalents were increased slightly, the apparent yield increased to 82%. 1H NMR analysis later confirmed that the increase was due to the enhanced side-product (8a) formation, which precipitated out along with the product.
Aminopropylated cellulose (Cell-NH2) performed very poorly, possibly due to the lower basicity of the primary amine group, as did Amberlyst® A26 and Amberlyst® A21 (Table 1, entries 17–20). The latter two are significantly basic (the former polymer has hydroxide ions ionically bonded to quaternary ammonium centres, whilst the latter has tertiary amine groups), and as such were expected to give appreciable yields. Yet, being spherical mesoporous beads, their surface area in contact with the reactants was relatively small. In addition, polymeric resins are often poisoned during the reaction, as could in fact be inferred from their change in colour. Metallic oxides (supported and free) all fared inadequately (Table 1, entries 21–30), mainly because of a significant amount of side-product (8a) formation. The supported heteropoly acids did not perform better either, which was possibly because the Knoevenagel condensation step occurs preferentially in basic conditions (Table 1, entries 31–32).
Interestingly, when nanomagnetite was synthesized in situ within montmorillonite K30 and then used as a catalyst (Table 1, entries 33–40), there was a significant improvement in yield, despite the fact that malononitrile was used in slight excess (1.2 equivalents) in all of the latter trials. In truth, the presence of the benzopyran side product (8a) could be noted in all collected products (5a) of the said entries (as per 1H NMR), and hence alternative catalysts had to be probed. Positively, the novel catalyst piperazine supported within agar (Pip–Agar) provided a very pure final product at the highest yield yet (80%) obtained when used at a molar concentration of 25% (Table 1, entry 44). Lower loading still provided a very pure final product (Table 1, entry 45), albeit at a lower yield, whereas the use of excess malononitrile and benzaldehyde was detrimental to final product purity because of benzopyran side-product (8a) formation. In an additional trial performed using only piperazine (25 mol%) as catalyst, significant side-product formation was observed. This side product precipitated out along with the product. Contrastingly, when untreated agar (0.3 g) was tried as a catalyst (entry not shown), with time it swelled up. As such, stirring could not ensue, even on adding ethanol solvent (+2 mL), and product formation was insignificant. Alternative amines or ionic liquids dispersed within the agar matrix gave average results when used as catalysts (Table 1, entries 46–48).

2.2. Expanding the DHP Substrate Scope

Having determined the ideal conditions (entry 44, Table 1), these were adopted for substrate screening. When the aldehyde was varied, yields ranged from 49% to 80% (entries 1–7, Table 2), with the lower values obtained from the electron-rich 4-methoxybenzaldehyde and the heteroaromatic thiophene-2-carbaldehyde. The former aldehyde furnished an electron-rich Knoevenagel product (after reacting with malononitrile), which was less likely to be then attacked by the enaminone and form the final product. Meanwhile, although in principle thiophene-2-carbaldehyde and benzaldehyde are relatively similar in terms of aromatic character, the former gave an inferior yield, mainly due to significant side-product formation (several minor spots could be observed on TLC plates during reaction monitoring).
The use of various substituted anilines furnished a set of novel compounds, with yields ranging from average to very good (entries 8–12, Table 2, 45–84%). Impressively, even the azo dye 4-(phenylazo)phenylamine yielded the final product (entry 15, Table 2, 54%), as did the other azo dye derived from 3-methylaniline (3-methyl-4-(3-methylphenylazo)phenylamine) (entry 16, Table 2, 23%). Aliphatic amines such as c-hexylamine and benzylamine (entries 13, 14, Table 2) performed poorly, with the former furnishing minute traces and the latter giving a yield of just 10%. Other aliphatic amines were explored (not shown in table), and no products could be collected in a pure form.
Replacing malononitrile with methyl cyanoacetate furnished the expected product (entry 8, Table 2) at an inferior yield (25%), which might be attributed to the lower α-hydrogen acidity and hence lower reactivity of methyl cyanoacetate with aldehyde. In addition, the resulting Knoevenagel product for attack by the enaminone (originating from the condensation of dimedone and aniline) is less electron-poor. Replacing dimedone with indanedione (3b) resulted in a complex reaction mixture with several side-product formations, and no expected product was collected (entry 17). On the other hand, cyclohexanedione (3c) (entries 18–19, Table 2) furnished the expected pure products, despite the fact that it was observed that in both instances the reaction mixture turned significantly dark over the course of the reaction, which was possibly due to product decomposition.
Upon substituting the aldehyde with isatin (6) to form various spiro-linked dihydropyridines (7), the yields were comparable to those reported in the literature (Table 3) [21]. However, one needs to point out that, to the best of our knowledge, this reaction has never been reported as having been performed in a heterogeneous fashion or under green conditions (the reported study used THF as the solvent) [21]. Furthermore, although at first sight the yields obtained when using 3- or 4-methylaniline (entries 2 and 7, Table 3) appeared odd, such values can be easily explained as follows. During the course of the reaction, isatin dimerized to form a deep-violet solid (the dimer was confirmed by 1H NMR and gave a purple spot-on TLC) that tended to precipitate out with the product during recrystallization from ethanol. The products derived from other amines were poorly soluble in acetone and ethanol and hence, upon washing the final collected products with acetone, the dimer could be removed while retaining the product. On the other hand, the products derived from the methyl-substituted anilines dissolved appreciably in acetone and hence upon washing a fraction of the products 7b and 7g ended up being lost. Regrettably the azo-linked aniline 1h did not furnish the expected product 7h in pure form due to side-product formation.

2.3. Catalyst Description and Recycling Runs

2.3.1. Optical Microscopy

The catalyst was prepared by first dissolving agar (2.0 g) (with heating), a natural polysaccharide of agarobiose with minor peptide components, in water (20 mL). Then, piperazine (3.0 mmol, 0.26 g) was duly added to the mixture and stirred well, and we then left it to set. Subsequently, once the formed gel had hardened, it was manually broken down (Figure 3) into small fragments (using a metal grater) before being heated and dried in an air oven set at 80 °C for 12 h (Figure 4). At this stage, the fragments had hardened and could be broken down into smaller shards via mechanical action (pestle and mortar).
The final catalyst was observed to be transparent shards when examined using optical microscopy (Figure 5i,ii). This confirmed that there were no aggregate formations and that piperazine was trapped in a dissolved state within the matrix.
SEM images (Figure 5iii,iv) helped to understand the size distribution (1–250 μm) and the irregular rough surface that the catalytic particles have. Smaller fragments are adsorbed to larger ones, and no particularly porous structure is noted. This results from the catalyst’s method of preparation (the drying of an aqueous gel).

2.3.2. IR Spectrum

When comparing the IR spectrum of agar (Figure 6 and Figure 7) with that of pip–agar, one swiftly notes the large OH stretching band at 3418 cm−1 for the latter due to the presence of water within the catalyst fragments. This band most certainly overlaps with the N-H stretching vibrations of the piperazine moieties. At 2181 cm−1, the pip–agar spectrum has a small peak that could be a result of a piperazine N-H-coupled stretching mode. In both spectra, the bands at 1651/1653 cm−1 are possibly an indication of carbonyl stretching caused by carboxylate moieties of the peptide components of agar, whereas the bands at 1456/1458 cm−1 and 1373/1377 cm−1 are likely caused by aliphatic C-H bending modes. The strong band at 1074/72 cm−1 is likely to derive from the C-O stretch of alcohol groups of the agarobiose rings. Other bands below 1000 cm−1 are a result of aliphatic C-H bending modes.
In order to confirm the loading of piperazine within the catalyst fragments, a specific mass of the latter was weighed and then transferred, with stirring, to boiling, deionised water in order to redissolve it. The resulting solution was titrated with hydrochloric acid using phenolphthalein as indicator (details in Section 3) and alkalinity was always found to be between 1.00 to 1.10 mmol/g.

2.3.3. Recycling Runs and Hot Filtration Test

Although the catalyst had several green aspects in terms of toxicity and preparation, the most important factor with respect to environmental benignity was its ability to be recycled easily and reused. In fact, considering its physical nature, catalyst recoverability was very simple, and filtration could be performed without difficulty and quickly as no filter pore blockage took place (as happens when filtering fine catalysts).
After leaving the recovered catalyst to dry to a constant weight in an air oven at 80 °C, it could be reused for up to 4 consecutive runs (Figure 8) for the model reaction, yielding 5a. The drop in yield could be attributed to minimal piperazine leaching or to catalyst poisoning, as the brown-deepening colour change suggested.
For the heterogeneity test, after mixing dimedone (3a) and aniline (1a) for 7 h to form the enaminone (as per usual procedure), malononitrile (4a) and benzaldehyde (2a) were added in that order, followed by the catalyst. Initially, the mixture was stirred in neat conditions before it thickened (after about 20 min). At this point, ethanol (2 mL) was added and, considering the physical nature of the catalyst (pip–agar), the reaction mixture could be easily decanted into another clean reaction flask and left to undergo stirring for 8 further hours at the original temperature of 85 °C. After purifying the reaction mixture, the product was collected at a paltry yield of 40%. In addition, TLC analysis during the course of the reaction did not elucidate any changes in the relative intensity of the enaminone intermediate and of the final product. The 1H NMR of the crude reaction mixture indeed showed an approximately 56% conversion rate (on comparing a singlet area of the enaminone to that of the product). All of this showed that the reaction stopped proceeding once the catalyst was removed, hence confirming that piperazine was significantly stable and did not leach over the course of the reaction.

2.4. Green Metrics of Model Reaction

The atom economy (AE), the E-factor, and the process mass intensity (PMI) for the model reaction (resulting in the formation of 5a) were calculated as tabulated in Table 4. The high atom economy is an intrinsic positive aspect of the reaction since the only by-product is water (two equivalents), while the E-factor is low due to minimal solvent use and a completely recoverable catalyst. Meanwhile, the total process mass intensity calculated below also takes into consideration the amount of solvent used during purification (approximately 20 mL of ethanol, needed for recrystallization) in order to provide a complete picture [24].

2.5. DHPs Derived from the Products of the Aza-Friedel–Crafts Multicomponent Reaction

As a further confirmation of the vast potential of multicomponent reactions in synthetic chemistry and of the functional group selectivity and catalytic ability of the catalyst conceived of, it was decided to try to synthesize N-aryl-4-aryldihydropyridines derived from another multicomponent reaction. To this effect, considering the free amino group in the final products, the indole derivatives depicted in Scheme 4 were synthesized by following our published method for the aza-Friedel–Crafts (AFC) reaction [25].
Thereafter, the same procedure described in Section 2.1 for the synthesis of 1-aryl-4-aryldihydropyridine (5) was followed to obtain the complex product (12, Scheme 5), fully characterised by IR, MS, 1H NMR, 13C NMR, DEPT135, 1H-1H COSY NMR, 1H-13C HSQC, and HMBC NMR (see Supplementary Information). To the best of our knowledge, this is a completely novel approach to synthesizing highly functionalized N-aryl-substituted DHPs and could prove to be a significant breakthrough in the history of the reaction. More so, such products or similar ones (using other derivative aldehydes, indoles, or amines) could potentially demonstrate high biological activity.

2.6. DHP Characterisation by Single and Two-Dimensional NMR Methods

The N-aryl DHP 5b was completely characterised by various NMR experiments (apart from IR and MS) to confirm its structure as well as peak assignments beyond reasonable doubt. Product 5b was specifically chosen (rather than model product 5a) due to the resolvable 1H NMR peaks that allowed for the performance of two-dimensional NMR experiments.
1H NMR spectrum of 5b
In the 1H NMR spectrum (Supplementary Materials), the recognisable pair of doublets at 7.24 and 7.12 ppm can be directly attributed to H2 and 6 and H1 and 5, respectively (the latter pair of hydrogens being ortho to the methyl group and hence rendered slightly more electron-rich than the former pair via a positive inductive effect). In the N-aryl moiety, H20–22 appear in the multiplet at 7.62–7.55 ppm, whereas H18 and 19 give a doublet-like peak at 7.33–7.28 ppm, evidencing that in this case the predominant factor affecting the electron–density distribution is its proximity to the electron-rich dihydropyridine moiety and the positive mesomeric effect exerted by the nitrogen.
A characteristic singlet at 4.72 ppm confirms the presence of H7, whilst the slightly broad peak at 3.99 ppm is because of hydrogens 25 (-NH2). Meanwhile, the methyl hydrogens (H29) appear at 2.31 ppm. Hydrogens 13 and 16 appear as a pair of doublets at 2.20 and 2.14 and at 2.04 and 1.81 ppm, respectively. The latter observation can be explained in terms of the geminal coupling of each distinct equatorial or axial hydrogen. The assignment of the pairs is confirmed below via 1H-13C HMBC. H27 and 28 also give two separate singlets at 0.96 and 0.85 ppm because the ring moiety to which they are bonded is restricted from fast axial–equatorial equilibration, rendering them non-chemically and magnetically equivalent.
13C, DEPT 135, 1H-13C HSQC, 1H-13C HMBC NMR spectra of product 5b
In order to confirm completely the structure of 5b, apart from the usual 13C and DEPT135 NMR spectra, two other experiments were conducted: a 1H-13C HSQC, showing direct C-H correlation, and a 1H-13C HMBC, showing long-range C-H correlations (all spectra available in Supplementary Information).
The easily attributable peak at 195.67 ppm is due to the carbonyl carbon atom C15, the peak of which is absent in DEPT135. C11 and C10 (both absent in DEPT135 spectrum) are likely to appear at 150.12 and 149.17 ppm, respectively, with the former being deshielded by two nitrogen atoms and the latter by one nitrogen atom only. In addition, they are sp2-hybridized (hence significantly deshielded compared to other C atoms). Further upfield, C3 (absent in DEPT135, confirmed via 1H-13C HMBC, as per the explanation below) is visible at 142.77 ppm. The two remaining quaternary aromatic carbon atoms that appear slightly further upfield are C4 and C17, which appear at 136.36 and 136.08 ppm, respectively (both absent in DEPT135). C22 would be the peak at 130.60 ppm, as can be understood from the cross-peak obtained in the HSQC spectrum.
C20 and 21 and C18 and 19 appear at 129.79 and 129.28 ppm, respectively (as per the presence of cross-peaks in 1H-13C HSQC). Meanwhile, C1 and 5 and C2 and 6 give peaks at 129.28 and 126.99 ppm, respectively, as per the 1H-13C HSQC spectrum. It is interesting to note that the attached hydrogens show an inverted chemical-shift relationship, with H2,6 being more deshielded than H1,5. This shows that the electron–density distribution in carbon atoms is less influenced by hyperconjugation effects, and more by electron-densities in its vicinity (the dihydropyridine ring). C23, being involved in a triple bond as well as aromatic carbons, is not deshielded and therefore appears upfield at 120.98 ppm. C8, absent in DEPT135 and in the vicinity of the carbonyl group (experiencing some of the negative inductive and ring-current effects), ought to be present at 113.32 pm, whereas C9 is much further upfield because it is shielded by the ring-current effects of the triple-bond system. C13 and C16 appear at 50.03 and 41.71 ppm, respectively (the former is sp3-hybridized but close to the carbonyl group). C7, an aliphatic carbon atom, ought to give rise to the peak at 35.64 ppm considering the DEPT spectrum and the fact that it is sp3-hybridized and more distant from the carbonyl group than C13. Lastly, C27 and C28 appear at 32.50 and 29.45 ppm, respectively, as two peaks of approximately equal heights, whereas C29 (rising slightly higher than previous two peaks) is the most shielded carbon atom at 21.11 ppm. The 1H-13C HMBC spectrum confirms several aspects of the above description by the presence of cross-peaks between long-range-coupled systems based on carbon protons:
(1)
C15 is long-range coupling with H13 only, hence confirming the above methylene assignment. Simultaneously, C10 and C11 are both coupled to H16, but not to H13.
(2)
H20 and 21 are long-range-coupled with C17, but H18 and 19 are not. This may seem strange but, in some instances (especially in para-substituted systems with chemically equivalent hydrogens on either side of the aromatic ring), the HMBC quantum filter removes two-bond correlations (along with single-bond correlations), leaving only three/four-bond correlations. In fact, C3 gives a cross-peak with H2 and 6 (three-bond correlation), while it does not with H1 and 5. In addition, there are two peaks, which are denoted as 20–21 and 18–19 due to three-bond correlations (H20-C21 or H21-C20 for the former and H18-C19 or H19-C18 for the latter).
(3)
H2 and 6 and H1 and 5 both give cross-peaks with C2,6 and C1,5, respectively. This may appear incorrect, but what is actually happening is a correlation between H2 and C6 or between C2 and H6 (three bond correlations), similar to what is observed between H/C 20–22.
(4)
H1 and 5 give a cross-peak with C4 (three-bond correlation). The identity of C4 is confirmed because it undergoes correlation with H7. Meanwhile, C3 is correlated to the methyl hydrogens H29 and with H2 and 6, as already mentioned.
(5)
H7 carries out long-range coupling with both C10 and C11, with C10 also carrying out long-range coupling with H16 (confirming the assignments of methylene hydrogens). H7 also carries out long-range coupling with C9, C8, C23, C4, C2, and 6.
(6)
H29s are able to give cross-peaks with C1 and 5 (three-bond correlation).
(7)
C15 carries out long-range three-bond coupling with H13 (visible cross-peak in expanded inset image), hence confirming the earlier assignments of the methylene hydrogens.
(8)
C8 is involved in long-range coupling with H7 (strongly), H16 (strongly), and with H13 (barely visible).
(9)
C9 is involved in long-range coupling with H7 (two-bond correlation) and H25 (three-bond correlation). The two-bond correlation between C9 and H7 is detected because of a small J coupling constant between the two that allows for peaks not to be filtered out by quantum filtering.
(10)
C23 is involved in long-range coupling (three-bond), with H7 confirming its identity.

3. Experimental

3.1. General Reaction Procedure

Dimedone (1.25 mmol) and aniline (1.25 mmol) were added in that order to a nitrogen-flushed dry 25 mL two-necked flask and stirred in neat conditions at 85 °C for 7 h. In cases when the magnetic stirring bar stopped rotating, 2–3 drops of ethanol (dry) were added. Subsequently, the catalyst (25 mol% of pip–agar, 0.28 g), malononitrile (1.50 mmol), and the aldehyde (1.25 mmol) were added, and a mixture was left to stir at 85 °C until the reaction mixture solidified (for the spiro-linked DHPs isatin (1.25 mmol) was used instead of the aldehyde). Then, ethanol (2 mL) was added. The reaction was monitored using TLC at 1–2 h intervals, and this was stopped until the complete consumption of the enaminone intermediate or until no further changes were observed. Subsequently, the reaction mixture was dissolved in hot acetone or ethanol, filtered using a G4 funnel, and then concentrated under vacuum conditions via rotary evaporation. The crude solid was recrystallized from ethanol (approximately 20 mL required).
For the complex dihydropyridine 12 derived from aza-Friedel–Crafts products, the latter were synthesized by following our reported procedure [25] before then employing the pure aza-Friedel–Crafts products in the same manner as outlined above (replacing the aniline). Hence, the aza-Friedel product in question (1.25 mmol) was stirred at 85 °C along with dimedone (1.25 mmol) in neat conditions (4–5 drops of ethanol added to aid stirring) for 8 h, before we then added the catalyst, malononitrile, and the aldehyde.

3.2. Pip–Agar Catalyst Preparation and Alkalinity Determination

Agar (2.0 g) was dissolved in boiling deionised water (20 mL) and stirred until the resulting mixture started to thicken slightly. Subsequently, piperazine (3 mmol) was added and the mixture was stirred for a further 5 min before being decanted into a shallow 250 mL petri dish and left to cool for 1 h in a refrigerator. Then, the hardened gel was broken down into small fragments using a metallic grater, before being heated in an air oven at 80 °C for 6–8 h until they started to turn brown in colour.
The same procedure was followed when infusing agar with DABCO, ethylenediamine diacetate, or hexamine.
In order to calculate the alkalinity, 0.1–0.2 g of the catalyst fragments was boiled in water (15 mL) until complete dissolution. This was then titrated with 0.02 M HCl, using phenolphthalein as an indicator, until we reached a transparent end point.

3.3. Other Catalyst Preparations

Piperazine/Morpholine (Morph)/Ethylenediamine (EDA) supported on Amberlyst 15® or Dowex® 50Wx8-50-100 [23]
We added 0.6 g of Amberlyst 15®, previously dried at 100 °C in an air-oven for 12 h, to a nitrogen-flushed dry 50 mL single-necked flask, followed by 1–2 mL of ethanol solvent. Subsequently, 0.4 g of the amines (piperazine, DABCO, morpholine, and ethylene diamine) was added to the flask. The mixture was left to stir for 48 h at RT, after which it was filtered through a G4 funnel. The solid catalyst was heated further for 12 h at 100 °C in an oil bath, and we then noted the mass difference compared to that of Amberlyst 15®. Finally, the catalyst was transferred to a pestle and mortar and ground into a fine powder.
The same procedure was followed when Dowex 50Wx8-50-100® was used as the acidic support.
Cellulose–NH2 (Cell-NH2)
Aminopropylated cellulose was prepared by following the method reported in [26].
Magnesium oxide, MgO-SiO2, MgO-MCM41
Nano-magnesium oxide was obtained by following the method reported in [27]. MgO-SiO2 was simply prepared via grinding a defined amount of nano-magnesium oxide in a pestle (for 15 min) with silica or nanoporous silica MCM41.
MCM41 was prepared by following the method reported in [28].
CaO–Boehmite
Boehmite was synthesized by following the method reported in [29]. Nano-CaO was also synthesized by following a reported procedure [30]; then, a specific amount of the two was ground together in a pestle for 15 min.
ZnO–Cellulose
Nano-zinc oxide was synthesized by modifying a method in the literature [31]. Essentially, nano crystalline cellulose (0.9399 g) was stirred at 700–800 rpm in water (50 mL) at room temperature, followed by the addition of 0.137 g (zinc (II) acetate dihydrate)). Subsequently, NaOH solution (0.33 g NaOH in 72 mL water) was added dropwise and then stirred overnight before being filtered and washed with water several times and then left to dry in a desiccator.
SnO2-MK30
Nano tin (IV) oxide was synthesized after executing the method reported in [32]. Thereafter, a specific amount of tin (IV) oxide was ground in a pestle (for 15 min) along with an amount of Montmorillonite K30.
Nano-Fe3O4-MK30
The catalyst was prepared by carrying out the method reported in [33].
WSi/PW-MK30
Both catalysts were obtained by completing the method described in [34].

3.4. Product Characterization Procedure

IR spectra were recorded on a Shimadzu IRAffinity-1 FTIR spectrometer (Kyoto, Japan) calibrated against 1602 cm−1 polystyrene absorbance spectra. After carrying out a background scan using KBr only, the samples were analysed as KBr pellets. The pellets were prepared by grinding about 5–10 mg of each separate sample with 100 mg of oven-dried potassium bromide with a pestle and mortar, before subjecting the samples to pressure in a screwable die. The final spectra were given as % transmittance against wavenumber (cm−1) and could be analysed and processed by the software IRsolution® ® ver. 1.10 before being exported as .txt files and then opened in MS Office Excel®.
The NMR spectra were recorded on a Bruker Avance III HD® NMR spectrometer, (Billerica, USA), equipped with an Ascend 500 11.75 Tesla superconducting magnet and operating at 500.13 MHz for 1H and 125.76 MHz for 13C, and a multinuclear 5 mm PABBO probe. Samples were dissolved in deuterated chloroform, DMSO, or acetone (with TMS). For 1H NMR, the product (3–5 mg) was dissolved in 0.8 mL of deuterated solvent, whilst for 13C NMR, DEPT135, 1H-13C HSQC, 1H-1H COSY, and 1H-13C HMBC spectra, the mass of product (dissolved in the same volume) was increased to 25–30 mg. The NMR spectra were analysed and processed using Topspin Software, ver. 3.2®, and MestreNova®, v12.0.2.
Mass spectra were performed using a Waters Acquity® TQD system, (Milford, MA, USA), equipped with a tandem quadrupole mass spectrometer, and analysed directly with a probe. The spectra were obtained in relative abundance compared to m/z and were generated by the software MassLynx®, ver. 4.2The melting points of products were determined using a Griffin® melting point determination apparatus (London, UK) fitted with a mercury thermometer. Three separate readings were taken, and the mean average was then calculated to achieve better accuracy.
Optical microscopy images were obtained using a Nikon Optiphot-100 light optical microscope (Tokyo, Japan) equipped with a Leica DFC290 digital camera (Wetzlar, Germany).
Scanning electron microscopy (SEM) images were obtained by analysing gold-spluttered samples adsorbed to double-sided carbon conducting tape fixed to a metallic stub. The instrument used was a cool-stage CoXem instrument (Daejeon, South Korea) with a tungsten electron source and an acceleration voltage that could vary from 1 to 30 kV. The detector could detect both secondary electronsand four sectors’ back-scattered electrons.

3.5. Product Characterization Data

[5a] 2-amino-7,8-dimethyl-5-oxo-1,4-diphenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 238–240 °C. IR (KBr) (ν, cm−1): 3333, 3221, 3055, 3022, 2959, 2901, 2868, 2180, 1653, 1595, 1572, 1491, 1418, 1373, 1261, 1146, 1042, 831, 741, 698. 1H NMR (500 MHz, Chloroform-d) δ 7.66–7.56 (m, 3H), 7.41–7.29 (m, 6H), 7.25–7.18 (m, 1H), 4.78 (s, 1H), 4.05 (s, 2H), 2.23 (d, J = 16.3 Hz, 1H), 2.17 (d, J = 16.3 Hz, 1H), 2.07 (d, J = 17.5 Hz, 1H), 1.83 (d, J = 17.7 Hz, 1H), 0.98 (s, 3H), 0.86 (s, 3H). ES(+) m/z = 370.12 [M+H].
[5b] 2-amino-7,8-dimethyl-4-(4-methylphenyl)-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 242–244 °C. IR (KBr) (ν, cm−1): 3460, 3339, 3217, 3040, 2953, 2903, 2868, 2180, 1657, 1620, 1595, 1572, 1493, 1414, 1373, 1260, 1242, 1182, 1146, 1126, 1040, 851, 758, 700, 646. 1H NMR (500 MHz, Chloroform-d) δ 7.62–7.55 (m, 3H), 7.33–7.28 (m, 2H), 7.24 (d, J = 8.2 Hz, 2H), 7.12 (d, J = 7.9 Hz, 2H), 4.72 (s, 1H), 3.99 (s, 2H), 2.31 (s, 3H), 2.20 (d, J = 16.4 Hz, 1H), 2.14 (dd, J = 16.3, 1.3 Hz, 1H), 2.04 (dd, J = 17.4, 1.2 Hz, 1H), 1.81 (dd, J = 17.4, 1.3 Hz, 1H), 0.96 (s, 3H), 0.85 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 195.67, 150.15, 149.17, 142.77, 136.36, 129.79, 129.28, 126.99, 120.98, 113.32, 63.67, 41.71, 35.64, 32.40, 29.45, 21.11.
[5c] 2-amino-4-(4-chlorophenyl)-7,8-dimethyl-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 268–270 °C. IR (KBr) (ν, cm−1): 3329, 3217, 3022, 2953, 2903, 2868, 2180, 1653, 1595, 1570, 1491, 1418, 1260, 1146, 1042, 1013, 845, 698. 1H NMR (500 MHz, Chloroform-d) δ 7.67–7.57 (m, 3H), 7.35–7.30 (m, 6H), 4.77 (s, 1H), 4.09 (s, 2H), 2.23 (d, J = 16.4 Hz, 1H), 2.16 (dd, J = 16.4, 1.3 Hz, 1H), 2.06 (dd, J = 17.5, 1.1 Hz, 1H), 1.82 (dd, J = 17.4, 1.3 Hz, 1H), 0.98 (s, 3H), 0.85 (s, 3H).
[5d] 2-amino-4-(2,4-dichlorophenyl)-7,8-dimethyl-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 256–258 °C. IR (KBr) (ν, cm−1): 3445, 3348, 3221, 3059, 2957, 2176, 1649, 1562, 1493, 1422, 1371, 1256, 1155, 1049, 864, 845, 723, 706. 1H NMR (500 MHz, Chloroform-d) δ 7.64–7.55 (m, 3H), 7.36 (d, J = 2.2 Hz, 1H), 7.34–7.28 (m, 3H), 7.21 (dd, J = 8.3, 2.2 Hz, 1H), 5.13 (s, 1H), 4.00 (s, 2H), 2.17 (d, J = 16.4 Hz, 1H), 2.11 (dd, J = 16.3, 1.3 Hz, 1H), 2.01 (dd, J = 17.5, 1.4 Hz, 1H), 1.83 (dd, J = 17.4, 1.3 Hz, 1H), 0.95 (s, 3H), 0.89 (s, 3H).
[5e] 2-amino-4-(4-fluorophenyl)-7,8-dimethyl-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 258–260 °C. IR (KBr) (ν, cm−1): 3333, 3217, 3182, 3067, 3034, 2959, 2891, 2870, 2181, 1655, 1595, 1493, 1416, 1375, 1317, 1259, 1219, 1155, 1043, 856, 762, 704. 1H NMR (500 MHz, Chloroform-d) δ 7.65–7.59 (m, 3H), 7.39–7.30 (m, 4H), 7.06–6.96 (m, 2H), 4.78 (s, 1H), 4.20–3.93 (m, 2H), 2.23 (d, J = 16.4 Hz, 1H), 2.16 (dd, J = 16.3, 1.3 Hz, 1H), 2.05 (dd, J = 17.4, 1.3 Hz, 1H), 1.82 (dd, J = 17.4, 1.3 Hz, 1H), 0.98 (s, 3H), 0.85 (s, 3H).
[5f] 2-amino-7,8-dimethyl-5-oxo-1-phenyl-4-thiophen-2-yl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 204–206 °C. IR (KBr) (ν, cm−1): 3321, 3213, 3059, 2959, 2932, 2870, 2180, 1641, 1595, 1564, 1493, 1414, 1375, 1260, 1144, 1040, 775, 760, 691. 1H NMR (500 MHz, Chloroform-d) δ 7.66–7.55 (m, 3H), 7.38–7.31 (m, 2H), 7.14 (dd, J = 5.1, 1.2 Hz, 1H), 7.04 (dd, J = 3.4, 1.0 Hz, 1H), 6.95 (dd, J = 5.1, 3.5 Hz, 1H), 5.13 (s, 1H), 4.12 (s, 2H), 2.27 (d, J = 16.3 Hz, 1H), 2.23 (dd, J = 16.2, 1.1 Hz, 1H), 2.08 (d, J = 17.5 Hz, 1H), 1.79 (dd, J = 17.4, 1.1 Hz, 1H), 0.99 (s, 3H), 0.89 (s, 3H).
[5g] 2-amino-7,8-dimethyl-5-oxo-1-phenyl-4-(3-nitrophenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. Yellow solid. M.P. 254–255 °C. IR (KBr) (ν, cm−1): 3466, 3329, 3217, 3067, 2961, 2872, 2181, 1653, 1598, 1568, 1524, 1418, 1375, 1350, 1258, 1148, 1045, 926, 826, 812, 737, 694. 1H NMR (500 MHz, DMSO-d6) δ 8.20–8.02 (m, 2H), 7.79 (d, J = 7.6 Hz, 1H), 7.67 (t, J = 8.3 Hz, 1H), 7.65–7.56 (m, 3H), 7.50–7.36 (m, 2H), 5.52 (s, 2H), 4.66 (s, 1H), 2.25 (d, J = 8.6 Hz, 1H), 2.21 (d, J = 8.6 Hz, 1H), 2.03 (d, J = 16.1 Hz, 1H), 1.74 (d, J = 17.5 Hz, 1H), 0.89 (s, 3H), 0.73 (s, 3H).
[5h] 2-amino-4-(4-methoxyphenyl)-7,8-dimethyl-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. White solid. M.P. 230–232 °C. IR (KBr) (ν, cm−1): 3460, 3331, 3219, 3067, 2992, 2957, 2940, 2897, 2872, 2837, 2178, 1641, 1510, 1414, 1375, 1256, 1240, 1179, 1144, 1036, 851, 818, 762, 706, 665. 1H NMR (500 MHz, Chloroform-d) δ 7.64–7.54 (m, 3H), 7.36–7.26 (m, 5H), 6.85 (d, J = 8.7 Hz, 2H), 4.71 (s, 1H), 3.98 (s, 2H), 3.78 (s, 3H), 2.20 (d, J = 16.3 Hz, 1H), 2.14 (dd, J = 16.3, 1.3 Hz, 1H), 2.03 (dd, J = 17.4, 1.3 Hz, 1H), 1.80 (dd, J = 17.4, 1.3 Hz, 1H), 0.95 (s, 3H), 0.84 (s, 3H).
[5i] Methyl 2-amino-4-(2,4-dichlorophenyl)-7,8-dimethyl-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate. Novel. White solid. M.P. 213–215 °C. IR (KBr) (ν, cm−1): 3437, 3364, 3256, 3198, 3057, 2955, 2870, 1665, 1595, 1491, 1439, 1373, 1275, 1213, 1180, 1045, 847, 816, 785, 760, 710, 625. 1H NMR (500 MHz, Chloroform-d) δ 7.68–7.56 (m, 3H), 7.46 (d, J = 8.3 Hz, 1H), 7.40–7.33 (m, 2H), 7.30 (d, J = 2.2 Hz, 1H), 7.17 (dd, J = 8.3, 2.2 Hz, 1H), 6.27 (s, 2H), 5.35 (s, 1H), 3.59 (s, 3H), 2.18 (d, J = 16.3 Hz, 1H), 2.10 (dd, J = 16.3, 1.5 Hz, 1H), 2.02 (dd, J = 17.4, 1.4 Hz, 1H), 1.79 (dd, J = 17.4, 1.4 Hz, 1H), 0.95 (s, 3H), 0.84 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 195.71, 170.32, 152.11, 149.95, 142.96, 136.22, 134.05, 133.41, 131.64, 130.53, 130.24, 130.19, 129.46, 126.32, 112.92, 79.03, 50.46, 49.99, 42.05, 34.77, 32.28, 30.93, 29.57, 26.84. ES(+) m/z = 471.30–475.27 ([M+H], isotopes).
[5j] 2-amino-7,8-dimethyl-5-oxo-1-(3-methylphenyl)-4-(3-nitrophenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel yellow solid. M.P. 246–248 °C.IR (KBr) (ν, cm−1): 3329, 3217, 3034, 2961, 2932, 2872, 2181, 1653, 1568, 1524, 1418, 1375, 1350, 1260, 1179, 1152, 1092, 1047, 789, 743, 694. 1H NMR (500 MHz, DMSO-d6) δ 8.19–8.03 (m, 2H), 7.78 (d, J = 7.6 Hz, 1H), 7.67 (t, J = 7.8 Hz, 1H), 7.50 (t, J = 7.7 Hz, 1H), 7.40 (d, J = 7.7 Hz, 1H), 7.32–7.12 (m, 2H), 5.51 (s, 2H), 4.65 (s, 1H), 2.41 (s, 3H), 2.23 (dd, J = 16.8, 11.3 Hz, 2H), 2.03 (d, J = 16.8 Hz, 1H), 1.79 (d, J = 17.5 Hz, 1H), 0.90 (s, 3H), 0.73 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 195.32, 152.09, 151.49, 149.17, 148.36, 140.57, 136.34, 134.20, 131.03, 130.63, 130.46, 127.25, 121.97, 121.62, 111.50, 59.66, 49.67, 41.38, 36.89, 32.45, 29.44, 26.72, 21.36. ES(+) m/z = 429.34 [M+H].
[5k] 2-amino-1-(3-chlorophenyl)-4-(2,4-dichlorophenyl)-7,8-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel white solid. M.P. 240–242 °C. IR (KBr) (ν, cm−1): 3466, 3343, 3217, 3067, 2955, 2901, 2870, 2183, 1657, 1618, 1589, 1570, 1468, 1373, 1260, 1146, 1103, 1047, 860, 795, 718, 702. 1H NMR (500 MHz, DMSO-d6) δ 7.70–7.58 (m, 3H), 7.52 (d, J = 2.1 Hz, 1H), 7.48–7.36 (m, 3H), 5.51 (s, 2H), 4.98 (s, 1H), 2.28–2.11 (m, 2H), 1.97 (d, J = 16.0 Hz, 1H), 1.78 (d, J = 17.4 Hz, 1H), 0.91 (s, 3H), 0.81 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 195.14, 151.60, 151.45, 143.51, 137.73, 134.66, 132.92, 131.98, 131.88, 131.76, 130.92, 130.60, 129.60, 128.90, 128.28, 121.23, 110.94, 59.51, 49.66, 41.48, 34.12, 32.41, 29.49, 26.99. ES(+) m/z = 471.30–477.23 ([M+H]+, isotopes).
[5l] 2-amino-4-(2,4-dichlorophenyl)-7,8-dimethyl-1-(3-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel yellow solid. M.P. 252–254 °C. IR (KBr) (ν, cm−1): 3377, 3331, 3227, 3096, 3069, 2972, 2955, 2870, 2189, 1661, 1649. 1H NMR (500 MHz, DMSO-d6) δ 8.41 (ddd, J = 8.2, 2.3, 1.3 Hz, 1H), 8.36 (t, J = 2.3 Hz, 1H), 7.92 (dt, J = 8.2, 1.3 Hz, 1H), 7.86 (t, J = 8.2 Hz, 1H), 7.53 (d, J = 2.2 Hz, 1H), 7.48 (d, J = 8.4 Hz, 1H), 7.40 (dd, J = 8.4, 2.2 Hz, 1H), 5.64 (s, 2H), 5.08–4.87 (m, 1H), 2.27–2.13 (m, 2H), 1.97 (d, J = 16.0 Hz, 1H), 1.79 (d, J = 17.4 Hz, 1H), 0.89 (s, 3H), 0.85 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 195.24, 151.60, 151.38, 149.29, 143.46, 137.48, 137.41, 133.00, 132.01, 131.78 (d, J = 1.9 Hz), 128.91, 128.22, 126.49, 125.28, 121.21, 111.01, 59.59, 56.51, 49.67, 41.57, 34.28, 32.44, 29.48, 26.93, 19.01. ES(+) m/z = 483.34–487.31 ([M+H], isotopes).
[5m] 2-amino-1-(4-methoxyphenyl)-7,8-dimethyl-4-(3-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel white solid. M.P. 172–174 °C. IR (KBr) (ν, cm−1): 3460, 3391, 3331, 3219, 3042, 3005, 2963, 2872, 2893, 2180, 1661, 1618, 1566, 1514, 1414, 1375, 1294, 1256, 1171, 1146, 1042, 1024, 851, 810, 779, 708. 1H NMR (500 MHz, Chloroform-d) δ 7.26–7.16 (m, 4H), 7.14 (d, J = 7.5 Hz, 1H), 7.08 (d, J = 8.3 Hz, 2H), 7.02 (d, J = 7.4 Hz, 1H), 4.72 (s, 1H), 4.06 (s, 2H), 3.92 (s, 3H), 2.37 (s, 3H), 2.26–2.14 (m, 2H), 2.07 (d, J = 17.5 Hz, 1H), 1.88 (dd, J = 17.4, 1.3 Hz, 1H), 1.00 (s, 3H), 0.89 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 195.65, 160.56, 150.47, 149.77, 145.64, 137.91, 130.78, 128.47, 128.44, 128.03, 127.44, 123.96, 121.06, 115.66, 113.19, 63.51, 58.45, 55.70, 49.98, 41.70, 35.91, 32.37, 29.50, 27.06, 21.65, 18.43. ES(+) m/z = 414.16 [M+H].
[5n] 2-amino-4-(2,4-dichlorophenyl)-7,8-dimethyl-1-(methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel white solid. M.P. 229–231 °C. IR (KBr) (ν, cm−1): 3472, 3333, 3237, 3067, 2959, 2870, 2183, 1653, 1628, 1570, 1474, 1425, 1379, 1240, 1175, 1049, 970, 943, 851, 835, 696. 1H NMR (500 MHz, Chloroform-d) δ 7.56–7.46 (m, 2H), 7.43 (t, J = 7.4 Hz, 1H), 7.37 (d, J = 2.0 Hz, 1H), 7.28–7.25 (m, 2H), 7.18–7.09 (m, 2H), 5.19 (s, 1H), 5.04 (d, J = 18.1 Hz, 1H), 4.93 (d, J = 18.1 Hz, 1H), 4.04 (s, 2H), 2.60 (d, J = 16.5 Hz, 1H), 2.33–2.15 (m, 4H), 1.09 (s, 3H), 1.05 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 195.14, 151.88, 151.24, 140.79, 135.81, 133.67, 132.91, 131.04, 129.87, 129.85, 128.68, 127.28, 125.05, 120.27, 112.73, 65.38, 49.80, 48.47, 40.27, 34.68, 33.09, 29.18, 27.36. ES(+) m/z = 452.08–457.25 ([M+H], isotopes).
[5o] 2-amino-1-cyclohexyl-7,8-dimethyl-5-oxo-4-(3-nitrophenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Traces collected of novel yellow solid. 1H NMR (500 MHz, Chloroform-d) δ 8.03 (dd, J = 8.1, 2.4 Hz, 1H), 7.98 (t, J = 2.1 Hz, 1H), 7.70 (d, J = 7.9 Hz, 1H), 7.44 (td, J = 7.9, 1.8 Hz, 1H), 4.82 (d, J = 2.6 Hz, 1H), 4.46 (d, J = 7.2 Hz, 2H), 3.72 (tt, J = 12.6, 3.5 Hz, 1H), 2.73 (d, J = 16.3 Hz, 1H), 2.35–2.20 (m, 4H), 2.03–1.86 (m, 3H), 1.84–1.66 (m, 4H), 1.45–1.29 (m, 2H), 1.23–0.95 (m, 8H).
[5p] 2-amino-4-(4-cyanophenyl)-7,8-dimethyl-1-(4-(phenylazo)phenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel orange solid. M.P. 238–240 °C. IR (KBr) (ν, cm−1): 3337, 3057, 2959, 2872, 2230, 2183, 1630, 1499, 1414, 1371, 1315, 1260, 1153, 1040, 868, 843, 777, 692, 584, 569. 1H NMR (500 MHz, Chloroform-d) δ 8.21–8.09 (m, 2H), 8.07–7.95 (m, 2H), 7.75–7.63 (m, 2H), 7.63–7.55 (m, 3H), 7.55–7.42 (m, 4H), 4.86 (s, 1H), 4.19 (s, 2H), 2.26 (d, J = 16.4 Hz, 1H), 2.22–2.08 (m, 2H), 1.93 (d, J = 17.6 Hz, 1H), 1.01 (s, 3H), 0.87 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 195.31, 152.53, 152.44, 152.34, 151.84, 151.12, 138.88, 132.99, 132.56, 131.95, 130.10, 128.52, 124.53, 123.19, 121.60, 119.43, 111.29, 109.64, 59.72, 49.72, 41.52, 37.56, 32.45, 29.45, 26.81. ES(+) m/z = 499.41 [M+H].
[5q] 2-amino-4-(2,4-dichlorophenyl)-7,8-dimethyl-1-(4-(3-methylphenylazo)-3-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel orange solid. M.P. 255–257 °C. IR (KBr) (ν, cm−1): 3489, 3393, 3157, 3126, 3084, 3063, 2957, 2870, 2179, 1734, 1653, 1603, 1568, 1470, 1418, 1373, 1261, 1176, 1109, 1047, 887, 864, 851, 793, 690, 669. 1H NMR (500 MHz, Chloroform-d) δ 7.81–7.72 (m, 3H), 7.45 (dd, J = 8.5, 7.5 Hz, 1H), 7.40–7.34 (m, 2H), 7.32 (d, J = 8.5 Hz, 1H), 7.27 (d, J = 2.2 Hz, 1H), 7.25–7.18 (m, 2H), 5.14 (s, 1H), 4.07 (d, J = 14.0 Hz, 2H), 2.81 (s, 3H), 2.49 (s, 3H), 2.19 (d, J = 16.4 Hz, 1H), 2.14 (d, J = 1.2 Hz, 1H), 2.12–2.05 (m, 1H), 1.94 (d, J = 17.4 Hz, 1H), 0.98 (s, 3H), 0.92 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 195.45, 152.82, 151.61, 150.30, 150.25, 140.74, 140.10, 139.30, 137.35, 133.83, 132.98, 132.80, 132.41, 131.70, 130.05, 129.14, 128.09, 127.28, 123.69, 120.71, 120.31, 117.83, 111.11, 61.99, 49.84, 41.82, 35.49, 32.43, 29.39, 27.24, 21.42, 17.74. ES(+) m/z = 570.35–574.34 ([M+H], isotopes).
[5s] 2-amino-4-(4-methylphenyl)-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. Brownish solid. M.P. 235–237 °C. IR (KBr) (ν, cm−1): 3314, 3211, 3063, 3044, 3013, 2953, 2930, 2889, 2866, 2183, 1638, 1618, 1595, 1568, 1512, 1495, 1456, 1414, 1371, 1310, 1267, 1192, 1136, 1080, 1005, 901, 837, 829, 760, 698, 550. 1H NMR (500 MHz, Chloroform-d) δ 7.64–7.54 (m, 3H), 7.38–7.31 (m, 2H), 7.28 (d, J = 7.3 Hz, 3H), 7.15 (d, J = 8.0 Hz, 2H), 4.80 (s, 1H), 4.01 (d, J = 14.3 Hz, 2H), 2.43–2.36 (m, 1H), 2.34 (s, 3H), 2.29 (ddd, J = 16.8, 12.1, 4.9 Hz, 1H), 2.24–2.15 (m, 1H), 2.06–1.98 (m, 1H), 1.92 (dp, J = 14.4, 4.8 Hz, 1H), 1.80 (dddt, J = 13.4, 12.1, 10.5, 4.7 Hz, 1H).
[5t] 2-amino-4-(4-chlorophenyl)-5-oxo-1-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile [14]. Yellow solid. M.P. 228–230 °C. IR (KBr) (ν, cm−1): 3318, 3215, 3063, 3044, 2972, 2949, 2893, 2185, 1638, 1618, 1595, 1566, 1491, 1414, 1373, 1269, 1246, 1192, 1138, 1090, 1016, 105, 903, 833, 760, 700, 637. 1H NMR (500 MHz, Chloroform-d) δ 7.66–7.55 (m, 3H), 7.37–7.28 (m, 6H), 4.82 (s, 1H), 4.06 (s, 2H), 2.39 (dt, J = 16.6, 4.8 Hz, 1H), 2.30 (ddd, J = 16.8, 12.0, 4.8 Hz, 1H), 2.25–2.14 (m, 1H), 2.07–1.98 (m, 1H), 1.93 (dp, J = 14.4, 4.8 Hz, 1H), 1.85–1.73 (m, 1H).
[7a] 2′-Amino-7‚7′-dimethyl-2,5′-dioxo-1′-phenyl-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile [21]. White solid. M.P. 304–306 °C. IR (KBr) (ν, cm−1): 3431, 3325, 3217, 3055, 3092, 3055, 2965, 2872, 2191, 1721, 1699, 1618, 1645, 1595, 1558, 1472, 1422, 1364, 1341, 1317, 1263, 1198, 103, 926, 743, 729, 689. 1H NMR (500 MHz, DMSO-d6) δ 10.21 (s, 1H), 7.67–7.56 (m, 3H), 7.48 (s, 2H), 7.18 (d, J = 7.3 Hz, 1H), 7.13 (td, J = 7.6, 1.3 Hz, 1H), 6.92 (td, J = 7.5, 1.0 Hz, 1H), 6.77 (d, J = 7.6 Hz, 1H), 5.35 (s, 2H), 2.12 (dd, J = 16.6, 13.8 Hz, 2H), 1.94 (d, J = 15.9 Hz, 1H), 1.82 (d, J = 17.3 Hz, 1H), 0.89 (s, 3H), 0.82 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 194.36, 179.93, 152.35, 151.58, 141.93, 137.14, 136.47, 130.78, 130.42, 128.15, 123.64, 121.86, 119.39, 110.88, 109.31, 61.42, 56.51, 49.79, 48.98, 41.85, 32.59, 28.70, 27.10, 19.04. ES(+) m/z = 411.13 [M+H].
[7b] 2′-Amino-7′‚7′-dimethyl-1′-(3-methylphenyl)-2,5′-dioxo-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile. Novel white solid. MPT: 304–306 °C. IR (KBr) (ν, cm−1): 3460, 3356, 3333, 3051, 2959, 2870, 2183, 1715, 1692, 1645, 1558, 1474, 1364, 1341, 1315, 1261, 1215, 1051, 743, 691. 1H NMR (500 MHz, DMSO-d6) δ 10.21 (s, 1H), 7.50 (t, J = 7.7 Hz, 1H), 7.44 (d, J = 7.6 Hz, 1H), 7.37–7.19 (m, 2H), 7.17 (d, J = 7.1 Hz, 1H), 7.14 (t, J = 7.4 Hz, 1H), 6.92 (t, J = 7.4 Hz, 1H), 6.77 (d, J = 7.6 Hz, 1H), 5.34 (s, 2H), 2.42 (s, 3H), 2.23–2.03 (m, 2H), 1.94 (d, J = 16.0 Hz, 1H), 1.86 (d, J = 17.2 Hz, 1H), 0.89 (s, 3H), 0.83 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 194.35, 179.95, 152.40, 151.57, 141.93, 140.62, 137.17, 136.31, 131.07, 130.48, 128.13, 127.31 (d, J = 50.2 Hz), 123.64, 121.86, 119.42, 110.81, 109.30, 61.29, 49.82, 48.97, 41.78, 32.61, 28.68, 27.15, 21.31. ES(+) m/z = 426.35 [M+H].
[7c] 2′-Amino-7′‚7′-dimethyl-1′-(3-nitrophenyl)-2,5′-dioxo-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile [21]. Light yellow solid. M.P. 324–326 °C. IR (KBr) (ν, cm−1): 3395, 3333, 3298, 3096, 2959, 2874, 2187, 1746, 1649, 1543, 1472, 1366, 1315, 1258, 1225, 1198, 1153, 1049, 926, 762, 725, 696, 675, 619, 579. 1H NMR (500 MHz, DMSO-d6) δν, cm−1): 3460, 3325, 3215, 3069, 1957, 1945, 2905, 2872, 2189, 1734, 1719, 1653, 1514, 1472, 1364, 1252, 1190. 1–49, 1028, 920, 851, 762, 739, 691. 1H NMR (500 MHz, DMSO-d6) δ 10.19 (s, 1H), 7.43 (d, J = 6.2 Hz, 1H), 7.35 (d, J = 8.4 Hz, 1H), 7.23–7.06 (m, 4H), 6.91 (td, J = 7.5, 1.0 Hz, 1H), 6.76 (d, J = 7.6 Hz, 1H), 5.36 (s, 2H), 3.86 (s, 3H), 2.14 (d, J = 17.3 Hz, 1H), 2.10 (d, J = 16.0 Hz, 1H), 1.93 (d, J = 17.0 Hz, 1H), 1.87 (dd, J = 17.3, 1.3 Hz, 1H), 0.90 (s, 3H), 0.83 (s, 3H).
[7e] 2′-Amino-1′-(4-chlorophenyl)-7′‚7′-dimethyl-2,5′-dioxo-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile [21]. White solid. M.P. 298–300 °C. IR (KBr) (ν, cm−1): 3420, 3329, 294, 3055, 2963, 2870, 2191, 1749, 1566, 1641, 1618, 1491, 1472, 1416, 1364, 1315, 1263, 1194, 1092, 1051, 1018, 918, 799, 756, 745, 689. 1H NMR (500 MHz, DMSO-d6) δ 10.20 (s, 1H), 7.73–7.62 (m, 2H), 7.52 (s, 2H), 7.18 (dd, J = 7.3, 1.2 Hz, 1H), 7.12 (td, J = 7.6, 1.3 Hz, 1H), 6.91 (td, J = 7.4, 1.0 Hz, 1H), 6.76 (d, J = 7.6 Hz, 1H), 5.55 (s, 2H), 2.15 (d, J = 17.3 Hz, 1H), 2.10 (d, J = 15.9 Hz, 1H), 1.93 (dd, J = 15.9, 1.2 Hz, 1H), 1.83 (dd, J = 17.3, 1.3 Hz, 1H), 0.90 (s, 3H), 0.83 (s, 3H).
[7f] 2′-Amino-1′-(4-bromophenyl)-7′‚7′-dimethyl-2,5′-dioxo-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile [21]. White solid. M.P. 300–302 °C. IR (KBr) (ν, cm−1): 3418, 3321, 3291, 3057, 2959, 2868, 2193, 1749, 1661, 1649, 1618, 1564, 1487, 1474, 1364, 1315, 1263, 1196, 1150, 1051, 1015, 916, 797, 754, 745, 689, 637, 623. 1H NMR (500 MHz, DMSO-d6) δ 10.20 (s, 1H), 7.80 (d, J = 7.5 Hz, 2H), 7.45 (s, 2H), 7.18 (dd, J = 7.3, 1.2 Hz, 1H), 7.12 (td, J = 7.6, 1.3 Hz, 1H), 6.91 (td, J = 7.5, 1.0 Hz, 1H), 6.76 (d, J = 7.6 Hz, 1H), 5.54 (s, 2H), 2.14 (d, J = 17.3 Hz, 1H), 2.10 (d, J = 16.0 Hz, 1H), 1.95 (d, J = 16.0 Hz, 1H), 1.83 (dd, J = 17.3, 1.2 Hz, 1H), 0.90 (s, 3H), 0.83 (s, 3H).
[7g] 2′-Amino-7′‚7′-dimethyl-1′-(4-methylphenyl)-2,5′-dioxo-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile [21]. White solid. M.P. 298–300 °C. IR (KBr) (ν, cm−1): 3435, 3321, 3215, 3092, 3059, 3024, 2959, 2870, 2189, 1722, 1697, 1645, 1558, 1508, 1474, 1364, 1341, 1315, 1261, 1198, 1152, 1051, 922, 752, 689, 627. 1H NMR (500 MHz, DMSO-d6) δ 10.20 (s, 1H), 7.42 (d, J = 7.8 Hz, 2H), 7.36 (s, 2H), 7.21–7.14 (m, 1H), 7.12 (td, J = 7.6, 1.3 Hz, 1H), 6.91 (td, J = 7.5, 1.0 Hz, 1H), 6.76 (d, J = 7.6 Hz, 1H), 5.32 (s, 2H), 2.42 (s, 3H), 2.12 (dd, J = 18.7, 16.6 Hz, 2H), 1.93 (d, J = 15.8 Hz, 1H), 1.85 (d, J = 17.2 Hz, 1H), 0.89 (s, 3H), 0.82 (s, 3H).
[7i] 2′-Amino-1′-(3-chlorophenyl)-7′‚7′-dimethyl-2,5′-dioxo-5′‚6′‚7′‚8′-tetrahydro-1H-spiro[indoline-3,4′-quinoline]-3′-carbonitrile. Novel white solid. M.P. 314–316 °C. IR (KBr) (ν, cm−1): 3437, 3325, 3264, 3078, 3051, 3017, 2955, 2870, 2191, 1749, 1653, 1589, 1568, 1472, 1418, 1364, 1317, 1265, 1196, 1194, 1152, 1096, 1051, 922, 887, 849, 810, 750, 718, 689, 677, 613. 1H NMR (500 MHz, DMSO-d6) δ 10.20 (s, 1H), 7.85–7.55 (m, 3H), 7.46 (s, 1H), 7.24 (s, 1H), 7.12 (td, J = 7.7, 1.3 Hz, 1H), 6.91 (td, J = 7.5, 1.0 Hz, 1H), 6.76 (d, J = 7.5 Hz, 1H), 5.55 (s, 2H), 2.25–2.02 (m, 2H), 1.98–1.89 (m, 1H), 1.83 (d, J = 17.3 Hz, 1H), 0.90 (s, 3H), 0.83 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 194.40, 179.91, 152.03, 151.52, 141.92, 137.84, 137.07, 134.75, 132.06, 130.82, 130.65, 129.49, 128.15, 123.87, 121.84, 119.37, 111.02, 109.27, 61.47, 49.83, 49.00, 41.78, 32.63, 28.72, 27.12. ES(+) m/z = 448.24 [M+H].
[12] 2-amino-1-[4-[(4-bromophenyl)(1H-indol-3-yl)methyl]phenyl]-7,8-dimethyl-5-oxo-4-(3-methylphenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile. Novel yellow solid. M.P. 170–174 °C. IR (KBr) (ν, cm−1): 3377, 3355, 3219, 3055, 2957, 2868, 2181, 1636, 1562, 1485, 1456,1408, 1371, 1258, 1146, 1103, 1042, 1009, 837, 743, 702, 615. 1H NMR (500 MHz, Chloroform-d) δ 8.12 (s, 1H), 7.48 (d, J = 8.5 Hz, 2H), 7.45–7.39 (m, 3H), 7.28–7.22 (m, 4H), 7.21–7.19 (m, 3H), 7.13 (d, J = 8.4 Hz, 2H), 7.09 (dt, J = 7.8, 1.8 Hz, 1H), 7.03 (ddt, J = 8.0, 6.9, 1.0 Hz, 1H), 6.68 (d, J = 1.2 Hz, 1H), 5.75 (s, 1H), 4.74 (s, 1H), 4.10 (d, J = 13.9 Hz, 2H), 2.35 (s, 3H), 2.25–2.14 (m, 2H), 2.06 (dd, J = 17.8, 7.5 Hz, 1H), 1.84 (d, J = 17.4, 1H), 0.99 (d, J = 6.3 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 195.71, 150.52/150.50, 149.75/149.74, 147.01, 144.73, 138.28, 136.84, 133.89/133.86, 131.62, 131.16, 129.68, 129.42, 129.00, 128.99, 128.55, 127.66, 126.70/126.69, 125.96, 124.07/124.06, 122.38, 120.86, 120.47, 119.54/119.53, 119.45/119.42, 118.76/118.71, 112.84, 111.46, 62.61/62.59, 49.96/49.60, 47.71/47.70, 35.76, 32.40, 29.45/29.44, 27.03, 21.57. ES(+) m/z = 669.51 [M+H].

4. Conclusions

A wide range (27 examples, 12 of which novel) of N-aryl-4-aryldihydropyridines were synthesized using a novel, cheap, mild, and metal-free biopolymer-based catalyst, pip–agar, via the combination of aldehydes or isatin, anilines, dimedone, and malononitrile or methyl cyanoacetate. Table 5 showcases the advantages of our developed system in comparison to previous studies (excluding the studies involving the two-component version of the reaction). In addition, in an innovative and unprecedented approach, one of the products of the aza-Friedel–Crafts multicomponent reaction, catalysed by a heterogeneous catalyst previously developed by the same authors (silicotungstic acid supported on Amberlyst® 15), was used instead of aniline in dihydropyridine synthesis to create a complex novel scaffold.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29081884/s1, Figures S1–S118: IR spectrum, NMR spectrum, MS spectrum, HSQC spectrum, HMBC spectrum and DEPT spectrum; Tables S1–S14: Fragmentation positions for peaks in MS spectrum.

Author Contributions

Conceptualization, G.B. and R.A.; methodology, R.A.; validation, G.B. and R.A.; investigation, R.A.; resources, G.B.; data curation, R.A.; writing—original draft preparation, R.A. and G.B.; writing—review and editing, G.B. and R.A.; supervision, G.B.; project administration, G.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the article or Supplementary Materials.

Acknowledgments

The authors would like to thank the University of Malta for providing the necessary infrastructure and financial assistance. Thanks also go to Joseph Buhagiar for assisting with SEM analysis, Sarah Schembri for mass spectrometry, Antonino Mazzonello for help with optical microscopy and Duncan Micallef for NMR spectroscopic analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Singh, M.S.; Chowdhury, S. Recent developments in solvent-free multicomponent reactions: A perfect synergy for eco-compatible organic synthesis. RSC Adv. 2012, 2, 4547–4592. [Google Scholar] [CrossRef]
  2. Bosica, G.; Abdilla, R. Recent advances in multicomponent reactions under operationally heterogeneous conditions. Catalysts 2022, 12, 725. [Google Scholar] [CrossRef]
  3. Paprocki, D.; Madej, A.; Koszelewski, D.; Brodzka, A.; Ostaszewski, R. Multicomponent reactions accelerated by aqueous micelles. Front. Chem. 2018, 6, 502. [Google Scholar] [CrossRef]
  4. Khelilkordi, Z.; Ziarani, G.M.; Mohajer, F.; Badiei, A.; Sillanpaa, M. Recent advances in the application of magnetic bio-polymers as catalysts in multicomponent reactions. RSC Adv. 2022, 12, 12672–12701. [Google Scholar] [CrossRef] [PubMed]
  5. Ziarani, G.M.; Kheilkordi, Z.; Mohajer, F.; Badiei, A.; Luque, R. Magnetically recoverable catalysts for the preparation of pyridine derivatives: An overview. RSC Adv. 2021, 11, 17456–17477. [Google Scholar] [CrossRef] [PubMed]
  6. Nandi, S.; Jamatia, R.; Sarkar, R.; Sarkar, F.K.; Alam, S.; Pal, A.K. One-pot multicomponent reaction: A highly versatile strategy for the construction of valuable nitrogen-containing heterocycles. ChemistrySelect 2022, 7, e202201901. [Google Scholar] [CrossRef]
  7. Cataldi, M.; Bruno, F. 1,4-dihydropyridines: The multiple personalities of a blockbuster drug family. Transl. Med. 2012, 4, 10–24. [Google Scholar]
  8. Bosica, G.; Demanuele, K.; Padron, J.M. One-pot multicomponent green Hantzsch synthesis of 1,2-dihydroyridine derivatives with antiproliferative activity. Beilstein J. Org. Chem. 2020, 16, 2862–2869. [Google Scholar] [CrossRef] [PubMed]
  9. Al-Said, M.S.; Ghorab, M.M.; Al-Dosari, M.S.; Hamed, M.M. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety. Eur. J. Med. Chem. 2011, 46, 201–207. [Google Scholar] [CrossRef]
  10. Ghorab, M.M.; Ragab, F.A.; Heiba, H.I.; Arafa, R.K.; El-Hossary, E.M. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety. Eur. J. Med. Chem. 2010, 45, 3677–3684. [Google Scholar] [CrossRef]
  11. Han, W.; Inoue, C.; Onizawa, T.; Oriyama, T. Synthesis of N-aryl4-arylhexahydroquinoline derivatives by reaction of cyclic enaminones with arylidenemalononitriles in DMSO. Synthesis 2021, 53, 1495–1502. [Google Scholar]
  12. Abaszadeh, M.; Seifi, M.; Asadipour, A. MgO as a heterogeneous base catalyst, catalyses multicomponent reaction of cyclic enaminoketones, malononitrile, and aromatic aldehydes, synthesis and reactivity. Synth. React. Inorg. Met. 2016, 46, 512–517. [Google Scholar] [CrossRef]
  13. Abaszadeh, M.; Seifi, M.; Asadipour, A. Ultrasound promotes one-pot synthesis of 1,4-dihydropyridine and imidazo[1,2-a]quinoline derivatives, catalyzed by ZnO nanoparticles. Res. Chem. Intermed. 2015, 41, 5229–5238. [Google Scholar] [CrossRef]
  14. Amirheidari, B.; Seifi, M.; Abaszadeh, M. Evaluation of magnetically recyclable nano-Fe3O4 as a green catalyst for the synthesis of mono- and bistetrahydro-4H-chromene and mono and bis-1,4-dihydropyridine derivatives. Res. Chem. Intermed. 2016, 42, 3413–3423. [Google Scholar] [CrossRef]
  15. Ahadi, N.; Mobinikhaledi, A.; Bodaghifard, M.A. One-pot synthesis of 1,4-dihydropyridines and N-arylquinolines in the presence of copper complex stabilized on MnFe2O4 (MFO) as a novel organic–inorganic hybrid material and magnetically retrievable catalyst. Appl. Organomet. Chem. 2020, 34, 5822–5834. [Google Scholar] [CrossRef]
  16. Singh, S.K.; Singh, K.N. DBU-catalyzed expeditious and facile multicomponent synthesis of N-arylquinolines under microwave irradiation. Montash. Chem. 2012, 143, 805–808. [Google Scholar] [CrossRef]
  17. Ghozlan, S.A.S.; Ahmed, A.G.; Abdelhamid, I.A. Regioorientation in the addition reaction of α-substituted cinnamonitrile to enamines utilizing chitosan as a green catalyst: Unambiguous structural characterization using 2D-HMBC NMR spectroscopy. J. Heterocycl. Chem. 2016, 53, 817–823. [Google Scholar] [CrossRef]
  18. Abaszadeh, M.; Seifi, M. Crown ether complex cation ionic liquids: Synthesis and catalytic applications for the synthesis of tetrahydro-4H-chromene and 1,4-dihydropyridine derivatives. J. Sulf. Chem. 2017, 38, 440–449. [Google Scholar] [CrossRef]
  19. Sanaei-Rad, S.; Saeidiroshan, H.; Mirhosseini-Eshkevari, B.; Ali Ghasemzadeh, M. Hexamethylenetetramine-based ionic liquid anchored onto the metal–organic framework MIL-101(Cr) as a superior and reusable heterogeneous catalyst for the preparation of hexahydroquinolines. Res. Chem. Intermed. 2021, 47, 2143–2159. [Google Scholar] [CrossRef]
  20. Gao, S.; Tsai, C.H.; Tseng, C.; Yao, C. Fluoride ion catalyzed multicomponent reactions for efficient synthesis of 4H-chromene and N-arylquinoline derivatives in aqueous media. Tetrahedron 2008, 64, 9143–9149. [Google Scholar] [CrossRef]
  21. Kang, S.R.; Lee, Y.R. Efficient one-pot synthesis of spirooxindole derivatives bearing hexahydroquinolines using multicomponent reactions catalyzed by ethylenediamine diacetate. Synthesis 2013, 45, 2593–2599. [Google Scholar] [CrossRef]
  22. Khodaei, M.M.; Bahrami, K.; Farrokhi, A. Amberlite IRA-400 (OH−) as a catalyst in the preparation of 4H-benzo[b]pyrans in aqueous media. Synth. Commun. 2010, 40, 1492–1499. [Google Scholar] [CrossRef]
  23. Bosica, G.; Abdilla, R. Piperazine-Amberlyst®15-catalysed synthesis of 2-amino-4H-chromenes, chromeno[2,3-b]pyridines and chromeno[2,3-d]pyrimidines. Tetrahedron Green Chem. 2023, 1, 100011. [Google Scholar] [CrossRef]
  24. Jimenez-Gonzalez, C.; Ponder, C.S.; Broxterman, Q.B.; Manley, J.B. Using the right green yardstick: Why process mass intensity is used in the pharmaceutical industry to drive more sustainable processes. Org. Process Res. Dev. 2011, 15, 912–917. [Google Scholar] [CrossRef]
  25. Bosica, G.; Abdilla, R. A regioselective one-pot aza-Friedel–Crafts reaction for primary, secondary and tertiary anilines using a heterogeneous catalyst. Green Chem. 2017, 19, 5683–5690. [Google Scholar] [CrossRef]
  26. Sabaqian, S.; Nemati, F.; Heravi, M.M.; Nahzomi, H.T. Copper(I) iodide supported on modified cellulose-based nano-magnetite composite as a biodegradable catalyst for the synthesis of 1,2,3-triazoles. Appl. Organomet. Chem. 2016, 31, e3660. [Google Scholar] [CrossRef]
  27. Daisy, S.L.; Mary, A.C.C.; Devi, K.; Prabha, S.S.; Rajendran, S.; Zahirullah, S.S. Magnesium oxide nanoparticles—Synthesis and characterisation. Int. J. Nano Corr. Sci. Eng. 2015, 2, 64–69. [Google Scholar]
  28. Enache, D.F.; Vasile, E.; Simonescu, C.M.; Culita, D.; Vasile, E.; Oprea, O.; Pandele, A.M.; Razvan, A.; Dumitru, F.; Nechifor, G. Schiff base-functionalised mesoporous silicas (MCM-41, HMS) as Pb(II) adsorbents. RSC Adv. 2018, 8, 176–189. [Google Scholar] [CrossRef]
  29. Ghorbani-Choghamarani, A.; Hajjami, M.; Tahmasbi, B.; Noori, N. Boehmite silica sulfuric acid: As a new acidic material and reusable heterogeneous nanocatalyst for the various organic oxidation reactions. J. Iran. Chem. Soc. 2016, 13, 2193–2202. [Google Scholar] [CrossRef]
  30. Habte, L.; Shiferaw, N.; Mulatu, D.; Thenepalli, T.; Chilakala, R.; Ahn, J.W. Synthesis of nano-calcium oxide from waste eggshell by sol-gel method. Sustainability 2019, 11, 3196. [Google Scholar] [CrossRef]
  31. Onyszko, M.; Markowska-Szczupak, A.; Rakoczy, R.; Paszkiewicz, O.; Janusz, J.; Gorgon-Kuza, A.; Wenelska, K.; Mijowska, E. The cellulose fibers functionalized with star-like zinc oxide nanoparticles with boosted antibacterial performance for hygienic products. Sci. Rep. 2022, 12, 1321–1323. [Google Scholar] [CrossRef] [PubMed]
  32. Maheswari, C.S.; Shanmugapriya, C.; Revathy, K.; Lalitha, A. SnO2 nanoparticles as an efficient heterogeneous catalyst for the synthesis of 2H-indazolo[2,1-b]phthalazine-triones. J. Nanostruct. Chem. 2017, 7, 283–291. [Google Scholar] [CrossRef]
  33. Thanh, N.D.; Hai, D.S.; Huyen, L.T.; Thuy, V.T.T.; Tung, D.T.; Van, H.T.K.; Toan, V.N.; Giang, N.T.K.; Tri, N.M. Fe3O4-MNPs@MMT-K10: A reusable catalyst for synthesis of propargyl 4-aryl-4H-pyran-3-carboxyles via one-pot three-component reaction under microwave-assisted solvent-free conditions. Res. Chem. Intermed. 2023, 49, 525–555. [Google Scholar] [CrossRef]
  34. Zhu, S.; Zhu, Y.; Gao, X.; Mo, T.; Zhu, Y.; Li, Y. Production of bioadditives from glycerol esterification over zirconia supported heteropolyacids. Bioresour. Technol. 2013, 130, 41–45. [Google Scholar] [CrossRef] [PubMed]
Molecules 29 01884 g001
Figure 1. Structures of N-aryl DHPs with significant biological activity [9,10].
Figure 1. Structures of N-aryl DHPs with significant biological activity [9,10].
Molecules 29 01884 g001
Molecules 29 01884 sch001
Scheme 1. MCR synthesis of N-aryl-4-alky/aryl dihydropyridines (5).
Scheme 1. MCR synthesis of N-aryl-4-alky/aryl dihydropyridines (5).
Molecules 29 01884 sch001
Molecules 29 01884 g002
Figure 2. Intermediates formed in the synthesis of N-aryl DHPs.
Figure 2. Intermediates formed in the synthesis of N-aryl DHPs.
Molecules 29 01884 g002
Molecules 29 01884 sch002
Scheme 2. Synthesis of spiro-linked dihydropyridines (7) using isatin (6) as a reactant instead of aldehyde.
Scheme 2. Synthesis of spiro-linked dihydropyridines (7) using isatin (6) as a reactant instead of aldehyde.
Molecules 29 01884 sch002
Molecules 29 01884 sch003
Scheme 3. Benzopyran side product (8a) formed via the combination of dimedone (3a), benzaldehyde (1a), and malononitrile (4a).
Scheme 3. Benzopyran side product (8a) formed via the combination of dimedone (3a), benzaldehyde (1a), and malononitrile (4a).
Molecules 29 01884 sch003
Molecules 29 01884 g003
Figure 3. Pip–agar broken down into small fragments (before heating).
Figure 3. Pip–agar broken down into small fragments (before heating).
Molecules 29 01884 g003
Molecules 29 01884 g004
Figure 4. Pip–agar broken down into small fragments (after heating).
Figure 4. Pip–agar broken down into small fragments (after heating).
Molecules 29 01884 g004
Molecules 29 01884 g005
Figure 5. Optical (i,ii) and scanning electron microscopy (SEM) images (iii,iv) of a fragment of pip–agar (different magnifications).
Figure 5. Optical (i,ii) and scanning electron microscopy (SEM) images (iii,iv) of a fragment of pip–agar (different magnifications).
Molecules 29 01884 g005
Molecules 29 01884 g006
Figure 6. IR spectrum of agar.
Figure 6. IR spectrum of agar.
Molecules 29 01884 g006
Molecules 29 01884 g007
Figure 7. IR spectrum of Pip–Agar.
Figure 7. IR spectrum of Pip–Agar.
Molecules 29 01884 g007
Molecules 29 01884 g008
Figure 8. Recycling runs for the synthesis of 5a (reaction time refers to the second part of the reaction after the reaction between dimedone and aniline).
Figure 8. Recycling runs for the synthesis of 5a (reaction time refers to the second part of the reaction after the reaction between dimedone and aniline).
Molecules 29 01884 g008
Molecules 29 01884 sch004
Scheme 4. Synthesis of AFC product (10) from aniline (1a), 4-bromobenzaldehyde (2k), and indole (9).
Scheme 4. Synthesis of AFC product (10) from aniline (1a), 4-bromobenzaldehyde (2k), and indole (9).
Molecules 29 01884 sch004
Molecules 29 01884 sch005
Scheme 5. Synthesis of N-aryl-substituted pyridone (12) derived from the indole derivative 10, dimedone (3a), aldehyde (2g), and Meldrum’s acid (11).
Scheme 5. Synthesis of N-aryl-substituted pyridone (12) derived from the indole derivative 10, dimedone (3a), aldehyde (2g), and Meldrum’s acid (11).
Molecules 29 01884 sch005
Table 1. Catalyst screening and optimisation trials for N-aryl-4-aryl DHP (5a) synthesis.
Table 1. Catalyst screening and optimisation trials for N-aryl-4-aryl DHP (5a) synthesis.
Molecules 29 01884 i001
Entry aCatalyst bAmount of CatalystTemperature (°C)/Time (hr)Solvent/Amount (mL)Molar Ratio 1a/2a/3a/4aYield of 5a (%) c
1Pip-A15
(2.72 mmol/g)		20 mol%85/7 + 7EtOH/21:1:1:164%
220 mol%85/2 + 7EtOH/21:1:1:147%
320 mol%85/7 + 1EtOH/21:1:1:111%
420 mol% + 0.2 g 4 Å MS f85/7 + 7EtOH/21:1:1:171%
520 mol% + 0.4 g 4 Å MS f85/7 + 7EtOH/21:1:1:152%
630 mol%85/7 + 7EtOH/21:1:1:163%
730 mol%85/7 + 16EtOH/21:1:1:174%
8Ethylenediamine-A15
(2 mmol/g)		25 mol%85/7 + 7EtOH/21:1:1:163%
9Morpholine-A15
(2.00 mmol/g)		20 mol%85/7 + 7EtOH/21:1:1:1-
10Pip–Dowex
(2.4 mmol/g)		20 mol%85/7 + 16EtOH/21:1:1:167%
1125 mol%85/7 + 16EtOH/21:1:1:170%
1225 mol%95/7 + 16 i-PrOH/21:1:1:165%
13Pip–Dowex
(2.1 mmol/g)		40 mol% 85/7 + 7
85/7 + 12		EtOH/2 1:1:1:166%
69%
1440 mol%85/7 + 7EtOH/2 1:1:1:1.261%
1530 mol% 85/7 + 7EtOH/21:1:1:1.267%
1630 mol% 85/7 + 7EtOH/21:1.3:1:1.382% g
17Cell-NH2
(0.5 mmol/g)		5 mol%90/4 + 4EtOH/21:1:1:148%
1820 mol%85/7 + 16EtOH/21:1:1:146%
19A21 (dry)0.2 g85/7 + 8EtOH/21:1:1:153%
20A26 (dry)0.3 g 85/7 + 14EtOH/21:1:1:122%
21MgO40 mol%85/7 + 4EtOH/21:1:1:157%
2220 mol%85/7 + 7EtOH/21:1:1:161%
23MgO-SiO2
(63–200 um)
(4 mmol/g)		10 mol%85/7 + 7EtOH/21:1:1:142%
2420 mol%85/7 + 7EtOH/21:1:1:146%
25MgO-nano-MCM41
(4.5 mmol/g)		20 mol%85/7 + 16EtOH/21:1:1:160%
26CaO–Boehmite
(20% w/w, 3.6 mmol/g)		10 mol%85/7 + 7EtOH/21:1:1:154%
27SnO-MK30
(1 mmol/g)		10 mol%85/7 + 7EtOH/21:1:1:1.252%
28ZnO–Cellulose0.1 g85/7 + 7EtOH/21:1:1:1.267%
290.125 g85/7 + 7EtOH/21:1:1:1.257%
300.08 g85/7 + 7EtOH/21:1:1:1.243%
31WSi-MK30
(10% w/w)		0.1 g
(0.3 mol%)		85/7 + 7EtOH/21:1:1:1.265%
32PW-MK30
(10% w/w)		0.1 g
(0.3 mol%)		85/7 + 7EtOH/21:1:1:1.259%
33MK30-nano-Fe3O40.1 g85/7 + 7EtOH/21:1:1:1.270%
340.1 g 85/7 + 7EtOH/21:1.3:1:1.379% g
350.125 g85/7 + 7EtOH/21:1:1:1.267%
360.075 g85/7 + 7EtOH/21:1:1:1.261%
370.1 g85/7 + 7EtOH/H2O
(7:3)/2		1:1:1:1.265%
380.1 g + 0.1 g 4 Å MS f85/7 + 7EtOH/21:1:1:1.270%
390.1 g85/12 + 7EtOH/21:1:1:1.272%
400.1 g85/7EtOH/21:1:1:1.270% h
41Pip–Agar
(1.10 mmol/g)		25 mol%85/7 + 7EtOH/21:1.3:1:1.380% g
4220 mol%85/7 + 7EtOH/21:1.3:1:1.376% g
4325 mol%85/7 + 7EtOH/21:1:1:1.270%
4485/7 + 8EtOH/21:1:1:1.280% i
4517 mol%85/7 + 7EtOH/21:1:1:1.261%
46Ethylenediamine diacetate–Agar
(1 mmol/g)		20 mol%85/7 + 7EtOH/21:1:1:1.265%
47Hexamine–Agar
(1 mmol/g)		20 mol%85/7 + 16EtOH/41:1:1:1.244%
48DABCO–Agar
(1 mmol/g)		20 mol%85/7 + 16EtOH/41:1:1:1.268%
a Reactions were performed on a 1.25 mmol scale. In each trial, the amine and dimedone were reacted in neat conditions together before we then added malononitrile and aldehyde, followed by the catalyst and solvent. b All catalysts were prepared as per the methods in the Section 3. c The yield of pure final collected product (5a) after purification of crude reaction mixture by recrystallization from ethanol. f 4 Å Molecular sieves were added along with the stated catalyst. g The overall collected product (supposedly 5a) was slightly impure (approx. 10%, as per 1H NMR) due to the presence of benzopyran side product (8a). h In this trial, enaminone was synthesized and purified beforehand. i The product was very pure (no side-product traces as per 1H NMR).
Table 2. Yields and reaction times for the synthesis of various N-aryl-4-aryl DHP derivatives (5b–t).
Table 2. Yields and reaction times for the synthesis of various N-aryl-4-aryl DHP derivatives (5b–t).
Molecules 29 01884 i002
Entry aAmine
(1)		Aldehyde
(2)		Diketone
(3)		Active-Methylene Compound (4)Yield % (Time, hrs) b
[Product Code]
1C6H5NH2
(1a)		4-Me-C6H4CHO
(2b)		Molecules 29 01884 i003
(3a)		X = CN
(4a)		71% (7 + 8)
[5b]
21a4-Cl-C6H4CHO
(2c)		3a4a78% (7 + 8)
[5c]
31a2,4-Cl2-C6H3CHO
(2d)		3a4a80% (7 + 8)
[5d]
41a4-F-C6H4CHO
(2e)		3a4a72% (7 + 8)
[5e]
51aMolecules 29 01884 i004
(2f)		3a4a49% (7 + 8)
[5f]
61a3-NO2-C6H4CHO
(2g)		3a4a79% (7 + 8)
[5g]
71a4-OCH3-C6H4CHO
(2h)		3a4a58% (7 + 8)
[5h]
8
(Novel)		1a2d3aX = COOMe
(4b)		25% (7 + 8)
[5i]
9
(Novel)		3-Me-C6H4NH2
(1b)		2g3a4a84% (7 + 8)
[5j]
10
(Novel)		3-Cl-C6H4NH2
(1c)		2d3a4a83% (7 + 8)
[5k]
11
(Novel)		3-NO2-C6H4NH2
(1d)		2d3a4a84% (7 + 8)
[5l]
12
(Novel)		4-OCH3-C6H4NH2
(1e)		3-Me-C6H4CHO
(2i)		3a4a45% (7 + 8)
[5m]
13
(Novel)		BnNH2
(1f)		2d3a4a10% (7 + 8)
[5n]
14c-hexylNH2
(1g)		2g3a4a−(7 + 5) c
[5o]
15
(Novel)		Molecules 29 01884 i005
(1h)		4-CN-C6H4CHO
(2j)		3a4a53% (7 + 8)
[5p]
16
(Novel)		Molecules 29 01884 i006
(1i)		2d3a4a23% (7 + 9)
[5q]
171a2aMolecules 29 01884 i007
(3b)		4a−(7 + 2) d
[5r]
181a2bMolecules 29 01884 i008
(3c)		4a65% (7 + 8)
[5s]
191a2c3c4a64% (7 + 8)
[5t]
a All reactions were performed on a 1.25 mmol scale using a molar reactant ratio for 1, 2, 3, 4 of 1:1:1:1.2 in the presence of ethanol (2 mL) at a temperature of 85 °C using 25 mol% pip–agar catalyst; b Yield refers to the pure final collected product. Reaction time includes the time during which 1 and 3 were stirred in neat conditions in the absence of catalyst before the addition of 2 and 4. c Only small traces of product were collected after column chromatography d No product was collected due to the complex mixture of products formed.
Table 3. Synthesis of spiro-linked N-aryl-4-aryl dihydropyridines (7a–i) using isatin (6) instead of an aldehyde.
Table 3. Synthesis of spiro-linked N-aryl-4-aryl dihydropyridines (7a–i) using isatin (6) instead of an aldehyde.
Molecules 29 01884 i009
Entry aAniline R1
(Reactant Code)		Yield % (Time, hrs) b
[Product Code]
1H
(1a)		78% (7 + 8)
[7a]
2
(Novel)		3-Me-
(1b)		19% (7 + 8)
[7b]
3
(Novel)		3-NO2-
(1d)		79% (7 + 8)
[7c]
44-OCH3-
(1e)		60% (7 + 8)
[7d]
54-Cl-
(1j)		68% (7 + 8)
[7e]
64-Br-
(1k)		72% (7 + 8)
[7f]
74-Cl-
(1l)		20% (7 + 8)
[7g]
8Molecules 29 01884 i010
(1h)		-
[7h]
9
(Novel)		3-Cl-
(1c)		53% (7 + 8)
[7i]
a All reactions were performed on a 1.25 mmol scale using a molar reactant ratio for 1, 6, 3a, and 4a of 1:1:1:1.2 in the presence of ethanol (2–3 mL) at a temperature of 85 °C using 25 mol% pip–agar–agar catalyst. b Yield refers to that of pure final collected product after the necessary purification. Reaction time includes the time during which 1 and 3 were stirred in neat conditions in the absence of the catalyst before the addition of 6, 4a, and the catalyst.
Table 4. Green metrics calculations.
Table 4. Green metrics calculations.
A t o m   E c o n o m y = M o l e c u l a r   w e i g h t   o f   p r o d u c t ∑ m o l e c u l a r   w e i g h t   o f   r e a c t a n t s × 100

= 369.46 ( 140.18   d i m e d o n e + 93.13   a n i l i n e + 106.12 a l d e h y d e + 66.06   m a l o n o n i t r i l e
                = 91 %
E − f a c t o r = t o t a l   m a s s   o f   w a s t e t o t a l   m a s s   o f   p r o d u c t
Total mass of waste = mass of starting materials − (mass of product + mass of recovered catalyst)
Total mass of reactants = 0.00125 × (140.18 + 93.13 + 106.12) = 0.507 g
Total mass of catalyst = 0.28 g (complete mass recovery)
Total mass of solvent = 2 mL × 0.789 g/mL = 1.578 g
Total mass of product = 0.80 × 369.46 × 0.00125 = 0.369 g
 
Hence,
E − f a c t o r = 0.507 + 1.578 + 0.28 − 0.369 + 0.28 0.369 = 4.65  
P r o c e s s   M a s s   I n t e n s i t y = t o t a l   m a s s   o f   s t a r t i n g   m a t e r i a l s t o t a l   m a s s   o f   p r o d u c t
= 0.507   r e a c t a n t s + 0.28   c a t a l y s t + 1.578   r e a c t i o n   s o l v e n t + 15.78   p u r i f i c a t i o n   s o l v e n t 0.369
= 49.17
Table 5. This work’s advantages/disadvantages in comparison to those of previous studies.
Table 5. This work’s advantages/disadvantages in comparison to those of previous studies.
Paper Authors
(Year) [Reference]		ConditionsMain AdvantagesMain Drawbacks
Singh, S.K. et al. (2012) [16]5 mol% DBU
MW (140/120 W)
EtOH, 80 °C, 3–5 min
92–99%, 23 examples		Short reaction time, excellent yieldsHomogeneous catalyst (non-recoverable)
No substituted anilines and no isatin used
Pre-formed pure enaminone
Abaszadeh, M. et al. (2015) [12]55 mol% MgO
EtOH, 17–43 min
87–92%, 18 examples		Short reaction time, excellent yieldsNo recycling runs
Metallic catalyst
No substituted anilines and no isatin used
Preformed enaminone
Abaszadeh, M. et al. (2015) [13]10 mol% ZnO
EtOH, 80 °C, 27–55 min
88–92%, 18 examples		Short reaction time, excellent yields
Recyclable		Metallic catalyst
No substituted anilines and no isatin used
Preformed pure enaminone
Abaszadeh, M. et al. (2016) [14]10 mol% Fe3O4
EtOH, 80 °C, 4–15 min
87–95%, 20 examples		Short reaction time, excellent yieldsMetallic catalyst
No substituted anilines and no isatin used
Preformed pure enaminone
No recycling runs
Abasadeh, M. et al. (2016) [18]30 mol% Crown ether
EtOH/H2O, reflux 12–20 min
87–91%, 16 examples		Short reaction time, excellent yieldsNo substituted anilines and no isatin used
No recycling runs
Preformed pure enaminone
Sanaei-Rad, S. et al. (2021) [19]MIL-101(Cr)
Neat, reflux 10–20 min
92–98%, 14 examples		Short reaction time, excellent yields,
recyclable catalyst, one-pot method		Toxic metal containing catalyst (Cr)
Hazardous solvents in catalyst preparation
No heteroaromatic aldehydes and no isatin used
This study25 mol% pip–agar
EtOH, 7 + 8 hrs
27 examples		Cheap metal-free easy-to-prepare biopolymer catalyst
Recyclable
Union of MCRs possible
Use of substituted anilines and isatin
One-pot method		Long reaction times
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bosica, G.; Abdilla, R. Novel Biopolymer-Based Catalyst for the Multicomponent Synthesis of N-aryl-4-aryl-Substituted Dihydropyridines Derived from Simple and Complex Anilines. Molecules 2024, 29, 1884. https://doi.org/10.3390/molecules29081884

AMA Style

Bosica G, Abdilla R. Novel Biopolymer-Based Catalyst for the Multicomponent Synthesis of N-aryl-4-aryl-Substituted Dihydropyridines Derived from Simple and Complex Anilines. Molecules. 2024; 29(8):1884. https://doi.org/10.3390/molecules29081884

Chicago/Turabian Style

Bosica, Giovanna, and Roderick Abdilla. 2024. "Novel Biopolymer-Based Catalyst for the Multicomponent Synthesis of N-aryl-4-aryl-Substituted Dihydropyridines Derived from Simple and Complex Anilines" Molecules 29, no. 8: 1884. https://doi.org/10.3390/molecules29081884

Article Metrics

Back to TopTop